Skip to main content
. Author manuscript; available in PMC: 2020 Nov 18.
Published in final edited form as: Nat Genet. 2020 May 18;52(7):662–668. doi: 10.1038/s41588-020-0623-4

Table 1:

Summary Table.

Type of profiling p53 status # of unique cell lines % cell lines w/ >100 genes deregulated (>2X) % cell lines w/ p53 pathway activation % cell lines w/ emergence or expansion of a p53 mutation (ΔAF>0.05)
Gene expression WT 43 44.2% 32.6% NA
Mutant 122 43.4% 9.1%
WB + RT-qPCR WT 5 NA 80% NA
Mutant 4 0%
Targeted DNA sequencing WT 14 NA NA 10%
Mutant 26

Shown are the number of TP53-WT and TP53-mutant cell lines that were included in each experimental assay, the % of cell lines with > 100 genes deregulated by > 2 fold-change (FC), the % of cell lines with significant activation of the p53 pathway, and % of cell lines with emergence or expansion of a functional TP53 mutation (ΔAF > 0.05).

HHS Vulnerability Disclosure